Anteilseigner
BVF Partners LP (13,89 %) Armistice Capital LLC (9,49 %) ALS Therapy Development Foundation, Inc. (5,48 %) The Vanguard Group, Inc. (4,00 %) Woodline Partners LP (2,69 %) Ensign Peak Advisors, Inc. (1,83 %) Geode Capital Management LLC (0,75 %) CM Management LLC (0,66 %) Susquehanna Financial Group LLLP (0,41 %) Next Edge Capital Corp. (0,37 %) Renaissance Technologies LLC (0,36 %) JMAC Enterprises LLC (0,24 %) Ingalls & Snyder LLC (0,21 %) Schonfeld Strategic Advisors LLC (0,21 %) SSgA Funds Management, Inc. (0,18 %) Northern Trust Investments, Inc.(Investment Management) (0,16 %) BlackRock Fund Advisors (0,11 %) Marco Investment Management LLC (0,10 %) Mercer Global Advisors, Inc. (0,07 %) Citadel Securities LLC (0,07 %)
Kontakt
Eledon Pharmaceuticals Inc.